Skip Navigation

  • Weekly Notice of JHU Limited Submission Opportunities 

    Along with limited submissions updates, the Office of the Vice Provost for Research (VPR) is also maintaining the JHU COVID-19 Response websiteSee the most recent updates listed below and contact us if you have any questions.

    You can also access all current COVID-19 funding opportunities here.

    Newly Added COVID-19 Opportunities

    SponsorProgramFundingDeadline

    National Institutes of Health (NIH)

    NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS

    Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations$250,000 (direct costs)6/10/2020 (applications accepted until 12/15/2020)
    Patient-Centered Outcomes Research Institute (PCORI)Phased Large Awards in Comparative Effectiveness Research (PLACER)$22M

    LOI: 9/29/2020

    Full app: 1/12/2021

    National Institutes of Health (NIH)

    NIDCR

    Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR$150,000 (direct costs)

    11/2/2020

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    New Opportunities for August 3, 2020

    SponsorProgramLimitMaximum Award AmountInternal Application Deadline
    Howard Hughes Medical InstituteGilliam Fellowships for Advanced Study8 (anticipated)$138,0008/31/2020
    Warren Alpert FoundationDistinguished Scholar Awards1$200,0009/8/2020

     

     

     

     

     

    Open Opportunities

    SponsorProgramLimitMaximum Award AmountInternal Application Deadline
    National Institutes of Health (NIH)NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)1$2,500,000 (direct costs)8/18/2020
    National Institutes of Health (NIH)Collaborative Program Grant for Multidisciplinary Teams (RM1 Clinical Trial Optional)1$8,750,000 (direct costs)9/9/2020
    National Institutes of Health (NIH)Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)1No limit9/1/2020
    National Institutes of Health (NIH)Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)1$3,000,0009/1/2020
    National Science Foundation (NSF)NSF INCLUDES Alliances: Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science1$10,000,0008/25/2020
    Kleberg FoundationMedical Research Program1$1,000,0008/13/2020
    The Greenwall FoundationGreenwall Faculty Scholars Program150% salary for 3 years, 10% IDC, $5,000/year travel and project support8/18/2020
    Association for Computing Machinery (ACM)Doctoral Dissertation Competition2$20,0008/20/2020
    Francis Family FoundationParker B. Francis Fellowship Program2 per department$225,0009/10/2020

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Limited Submissions are funding opportunities in which federal and private sponsors limit the number of proposals from an institution.  An internal competition is held in order to select the most competitive proposal(s) on behalf of the University.

    Applications are due by 11:59pm on the internal application deadline specified.  For more information, please contact us at resapp@jhu.edu.

    To see the most updated information on all current limited submission opportunities, please visit our website.

    PLEASE NOTE: A Coeus record should NOT be created for an internal application to a limited submission opportunity until selected as a JHU nominee.

  • JHU Research Response Website

    JHU Research Response Website
    JHU has developed a site with topical resources regarding JHU's COVID-19 research response

    This site serves as the primary point for communication regarding the COVID-19 event for all JHU research administration offices, including JHURA, Business and Research Administration (BARA) and the School of Medicine Office of Research Administration (ORA).

    This COVID-19 news summary will be sent weekly, but please bookmark the pages below and check back frequently, as the information is updated daily.

    NEW: COVID-19 Research Response Program

    Sponsor Guidance: Federal and Non-federal guidance: Weekly updates below.

    Federal Sponsor Guidance Non-federal Sponsor Guidance

    Research Administration FAQs: Read the NEW research administration FAQs regarding budgeting for changes in Fringe Benefits on sponsored project budgets and updated university guidance on NIH flexibilities. 

    Human Subjects: We are still in Phase 3 of the Phased Contingency Plan.

    Animal Care & Use

    COVID-19 Funding Opportunities

    COVID-19 Research Response Resources

    Personal Protective Equipment (PPE) Donation Drive 

    For the latest university updates, please visit JHU's COVID-19 Information page.    

  • Grants Calendar: COVID-19 Funding

    As part of our efforts to help institutions navigate the pandemic response, Hanover has produced a calendar on COVID-19-related funding opportunities. While many of the grants reviewed in this calendar are focused on medical research, we have included a broad range of opportunities from federal agencies, private foundations, and industry. We will continue to monitor COVID-19 funding through our weekly grant alerts, which are open to the public to sign-up.

    We hope this calendar is a useful planning tool for your institution. Please access the document using the link above or below.

    If you have any questions or you would like to learn more about our work with these programs, please contact Senior Grants Advisor, Clinton Doggett, for a brief conversation.


  • 2020 Health Equity Innovations Fund Grants from Genentech - Apply by August 10

    Genentech is accepting LOIs for its 2020 Health Equity Innovations Fund grants, which will provide awards ranging from $250,000 to $750,000 over 12-24 months. Funded proposals will develop, test, and/or scale strategies and interventions that reduce disparities and promote health equity. This call focuses on two aims: 1) advancing inclusive research; 2) promoting equity in care. Successful proposals will align with the aims and sub-objectives outlined below.

    Aim 1: Advancing Inclusive Research
    Genentech will consider proposals that advance the following sub-aims:

    • A. Support the development and adoption of sustainable approaches for engaging, enrolling, and retaining communities of color in clinical research
    • B. Deepen engagement between communities of color and research organizations, establishing meaningful partnerships and systems for accountability for research to serve the needs of patients of color
    • C. Innovate and evaluate strategies to adapt and/or decentralize clinical trials amidst theCOVID-19 pandemic, examining the extent to which these efforts improve access and inclusion of communities of color

    Aim 2: Promoting Equity in Care
    Genentech will consider proposals that advance the following sub-aims:

    • A. Identify, test, and/or embed innovations in care delivery to improve access, continuity, and quality of care for historically underserved communities, specifically communities of color Note: Proposals specifically exploring care delivery innovation needs presented by the COVID-19 pandemic (e.g., expansion of telemedicine and technology innovation, use of community health workers, reimagining site of care) are encouraged
    • B. Deepen engagement between communities of color and hospital and health systems through meaningful partnership and co-created solutions for improving access, quality, and equitable treatment
    • C. Strengthen hospital and healthcare system efforts to mitigate the impact of racial bias in healthcare service delivery and eliminate health disparities through: Accountability structures and processes for healthcare leadership and practitioners to identify and address bias and racism in healthcare delivery; Initiatives that advance individual and institutional capacity to root out racism and embed cultural and structural competency​ and trauma-informed practices; Addressing social factors that impede patients’ ability to manage their health, engage in care, and adhere to treatment

    An optional Q&A Webinar will be held July 22, 2020 12-1 p.m. PDT. Please sign up ​here ​​by July 21.

    LOI Deadline:​ August 10, 2020 at 11:59 p.m. PT

    For more information, visit:

    https://www.gene.com/assets/frontend/pdf/content/good/grants/2020_Health_Equity_Innovations_Fund_CGN.pdf

  • AACN Faculty Scholars Grant Program - Apply by August 14

    The Foundation for Academic Nursing is seeking applications for the AACN Faculty Scholars Grant Program. The program is aimed at highlighting the innovative work being led by nurse educators to redesign teaching and learning at AACN member schools. Funding for this program was provided by more than 150 nursing schools and organizations that contributed to AACN's 50th Anniversary Celebration program.

    Award Details

    A total of $100,000 in funding will be distributed to support four $25,000 faculty scholarship projects through 2022. Two awards will be offered in the 2020-2021 academic year, and two will be offered in the 2021-2022 academic year. The focus of these scholarly activities should reflect current issues in nursing education or practice and support of AACN's strategic prioritiesSee additional details on the grant program web page.

    How to Apply

    Before completing your application, please review the full Call for Applications. Applicants must apply via this online form and submit no later than August 14, 2020 at 11:59 pm (ET).

    Learn More                   Apply Now

    For questions, please contact Dr. Cynthia Leaver, AACN's Director of Academic Nursing Development, at cleaver@aacnnursing.org.

  • Johns Hopkins HIV and Heart, Lung, Blood, and Sleep Disorders Training Program - Apply by August 14

    The Johns Hopkins HIV and Heart, Lung, Blood, and Sleep Disorders Training Program (H3TP)

    The H3TP brings together experts from across the Johns Hopkins medical, public health, and basic sciences communities to train and develop a cadre of outstanding investigators who will advance knowledge and improve outcomes for people living with HIV infection (PLWH) and comorbid heart, lung, blood, and sleep (HLBS) disorders. This program is funded by a National Institutes of Health K12 grant and is directly in line with both the National Heart, Lung, and Blood Institute’s mission and the Office of AIDS Research’s high-priority research issues to address comorbidities in the setting of aging with HIV. 

    Key Features:

    • Supports both postdoctoral fellows and junior faculty for 1-3 years for up to $100,000 a year
    • Provides rigorous training experience for trainees to develop a niche in HLBS and HIV research
    • Integrates multilayer and in-depth team mentorship individualized to each trainee’s career path
    • Utilizes access to the rich resources and research infrastructure available to Johns Hopkins HIV HLBS investigators
    • Engages trainees in high-caliber, collaborative research projects under guidance of nationally-renowned, multidisciplinary faculty
    • Builds trainees’ capacity for investigational methods, data interpretation, scientific reasoning, and other vital research skills, such as grant writing
    • Facilitates research success by providing access to high levels of methodological and analytic expertise possessed by our program leaders and mentors

    The H3TP is now soliciting applications from qualified candidates.

    Ideal Candidate:

    • Highly talented and motivated postdoctoral fellows and early-stage faculty from both clinical and non-clinical backgrounds
    • Willing to commit 75% effort to mentored research activities during funding period
    • Demonstrated interest in research and public health issues regarding HIV and HLBS diseases
    • Prior contribution to peer-reviewed publications
    • Commitment to develop and maintain a productive career with HIV and HLBS comorbidities
    • Enthusiasm for mentorship, multidisciplinary learning, and rigorous and collaborative research
    • Please note: All NIH Training Grants are restricted to US citizens and permanent residents

    How to Apply:
    Please email dmorga25@jhmi.edu to receive the application. Please complete and return by 23:59 EDT on Friday, August 14th, 2020 for consideration into the H3TP. We encourage applicants from diverse educational and underrepresented backgrounds to apply. Faculty endorsement is not required for this initial stage.

    We will review your application, including your CV and statement of research interests. Select candidates will then move on to a series of individual interviews with potential program mentors.

    Deadline: Friday, August 14th 2020

  • Community-Based Approaches to Strengthening Economic Supports for Working Families Initiative - Apply by August 17

    Award Ceiling: $450,000
    Award Floor: $300,000
    Estimated Total: $2,000,000
    Application Due Date: August 17, 2020, 6:00 PM ET 

    The Community-based Approaches to Strengthening Economic Supports for Working Families initiative will serve low-income working families disproportionately at risk for adverse childhood experiences (ACEs), including racial and ethnic minority families. This initiative seeks to determine whether implementation of earned income tax credit (EITC) outreach and education activities in communities at higher risk for ACEs can result in (1) increased EITC receipt and (2) changes in risk and/or protective factors for ACEs. OMH expects projects funded under this initiative to: (1) establish multi-sectoral partnerships to support EITC outreach and education activities in communities at higher risk for ACEs; (2) plan and implement EITC outreach and education activities in communities at higher risk for ACEs; (3) develop and implement a process and outcome evaluation plan; (4) communicate and disseminate findings, successes and lessons learned; and (5) plan for sustainability of successful interventions. 

    Click on the following link to access the funding opportunity announcement.

    Watch this technical assistance webinar recording  for interested applicants.

  • Reducing Cardiac Arrest Disparities Through Data Registries Initiative - Apply by August 17

    Award Ceiling: $70,000
    Award Floor: $50,000
    Estimated Total: $250,000
    Application Due Date: August 17, 2020, 6:00 PM ET 

    The Reducing Cardiac Arrest Disparities Through Data Registries Initiative supports demonstration projects to show whether participation in an out-of-hospital cardiac arrest (OHCA) registry using standard data collection tools and data infrastructure supports the: (1) identification of racial and ethnic minority and/or disadvantaged populations experiencing cardiac arrest; and (2) implementation of evidence-informed interventions to improve cardiac arrest survival rates.

    Click on the following link to access the funding opportunity announcement.

    Watch this technical assistance webinar recording  for interested applicants.

  • Centers of Excellence for Behavioral Health Disparities - Apply by August 19

    The Substance Abuse and Mental Health Services Administration (SAMHSA), is accepting applications for fiscal year (FY) 2020 Centers of Excellence (CoE) for Behavioral Health Disparities (Short Title: CoE-BH Disparities). The purpose of this program is to establish three Centers of Excellence to develop and disseminate training and technical assistance for healthcare practitioners on issues related to addressing behavioral health disparities. It is expected that the recipients will implement training and technical assistance for practitioners to address the disparities in behavioral healthcare in three key populations: African Americans, LGBTQ, and the aging population. SAMHSA will fund three Centers, each of which will focus on one of these populations.

    *SAMHSA has shortened the application timeline due to the need to award the grants by the end of the fiscal year.

    In addition, applicants are required to ensure their application is error-free by the due date and time. Applications will be returned to address errors but all applications must be error-free and submitted by the deadline to be considered. Please closely review Appendix A, especially 5.1 and 5.2, for more information.

    Link to Additional Information:https://www.samhsa.gov/grants/grant-announcements/fg-20-008
    Grantor Contact Information:

    If you have difficulty accessing the full announcement electronically, please contact:

    Corey Sullivan

    Office of Financial Resources, Division of Grants Management

    Substance Abuse and Mental Health Services Administration

    (240) 276-1213

    FOACMHS@samhsa.hhs.gov

  • Approaches to Advance Gender Equity From Around the Globe - Apply by August 26

    Through this special call for proposals (CFP), the Robert Wood Johnson Foundation’s Evidence for Action (E4A) program and Global Ideas for U.S. Solutions team seek to learn from programs, policies, and practices that are advancing gender equity around the world to understand how they can be adapted to improve health and well-being in the United States, and build a national Culture of Health.

    Please visit Evidence for Action to register for an applicant webinar, for information on office hours, and other applicant resources.

    The goal of this funding opportunity is to translate and adapt knowledge from around the world to the United States on approaches that can improve health or the determinants of health by improving gender equity. In the United States, determinants of health relate to personal safety, economic opportunity, education access (post-secondary or beyond), supportive workplace and social environments, and protection from bias and discrimination for vulnerable groups. We are especially interested in understanding how to change systems, norms, and practices—such as patriarchy and heterosexism—that systematically disfavor women, girls, and other groups based on gender or sexual identity. Specifically, we seek to learn from initiatives underway outside the United States whose effectiveness is supported or suggested by empirical evidence and that have the potential to be adapted and implemented in the United States.

    Total Awards:

    • Up to $1M USD will be awarded.
    • Individual awards will be between $100,000–$250,000 USD each.
    • The duration of awards will be up to 30 months.

    Deadline for submission for full proposals is August 26, 2020 (3 p.m. Eastern Time). Please visit this link for more information on how to apply.

  • State/Tribal/Territorial Partnership Initiative to Document and Sustain Disparity-Reducing Interventions - Apply by August 26

    Award Ceiling: $300,000
    Award Floor: $250,000
    Estimated Total: $6,500,000
    Application Due Date: August 26, 2020, 6:00 PM ET 

    The State/Tribal/Territorial Partnership Initiative to Document and Sustain Disparity-Reducing Interventions initiative supports projects to demonstrate if modifications to existing evidence-informed interventions for selected health issues will significantly improve health outcomes for racial and ethnic minority and disadvantaged populations. OMH intends projects funded under this initiative to help build the capacity of state, tribal, and territorial governmental health agencies to achieve two main goals: (1) test modifications to existing public health programs or practices (interventions) to assess if the modified interventions are successful in significantly improving health outcomes for selected health issues; and (2) develop effective plan(s) to sustain successful interventions after the award period. Projects are expected to address two health issues, one from each of the following two lists: (1) HIV, maternal mortality and morbidity, physical activity, or substance use disorder; and (2) nutrition, sickle cell disease and trait, diabetes, Alzheimer’s, lupus, or cancer prevention (i.e., addressing risk factor(s) specifically for stomach, liver, or cervical cancer).

    Click on the following link to access the funding opportunity announcement.

    Watch this technical assistance webinar recording  for interested applicants.

  • Lasker Clinical Research Scholars - Apply by August 28

    Positions Available: A Unique Bridge for Early Stage Clinical Investigators

    The National Institutes of Health, in partnership with the Lasker Foundation, is pleased to announce the 2020 Lasker Clinical Research Scholars Program. This is an opportunity for 8 to 10 years of funding for clinical researchers.

    This unique program provides Scholars with 5 to 7 years of support as an independent principal investigator in the NIH Intramural Research Program (IRP), followed by 3 years of continued financial support, either at the NIH or at an outside medical center/research institution.

    QUALIFICATIONS/ELIGIBILITY:

    Candidates must have a clinical doctoral degree (MD, MD/PhD, DO, DDS, DMD, RN/PhD or equivalent) and a professional license to practice in the United States. The program is intended for investigators at the early stages of their independent careers.

    Candidates generally will have completed or will be completing a post-residency clinical fellowship and will have demonstrated significant patient-oriented research experience to qualify for a tenure-track level appointment.

    TO APPLY:

    Learn more at http://www.nih.gov/science/laskerscholar/. The application deadline is August 28, 2020. Questions can be directed to Dr. Charles Dearolf, Director of Intramural Program Development and Support, at LaskerScholar@nih.gov. DHHS and NIH are Equal Opportunity Employers.

  • Proposals for the Equality Can't Wait Challenge from Pivotal Ventures - Register by September 1, Apply by September 22

    Pivotal Ventures, Melinda Gates’ investment and incubation company, with additional support from MacKenzie Bezos, has announced the launch of the Equality Can’t Wait Challenge. This new Challenge, managed by Lever for Change, will award $30 million to the organizations or coalitions of organizations with the most compelling proposals to expand women’s power and influence in the U.S. by 2030.

    The Equality Can’t Wait Challenge is seeking ideas that work in one or more key areas to expand women’s power and influence, including: dismantling the barriers that hold women back in their careers and at home, fast-tracking women in critical sectors by creating entry points and advancement opportunities, and calling society to action on gender equality.

    Competitive proposals will offer solutions that are transformative, equitable, innovative, and feasible. Proposals should also demonstrate that they can have measurable and rapid improvement in one or more of the following metrics: wages and wealth gap, unpaid care, leadership roles held by women, content created by women, or public perceptions of women’s power and influence.

    To apply to the competition, eligible organizations must register online before Tuesday, September 1, 2020. Applications are due by Tuesday, September 22, 2020 and will be assessed by expert reviewers and in a peer-to-peer review process. The Equality Can’t Wait Challenge is open to U.S.-based non-profit organizations or coalitions of organizations. At least two grants of a minimum of $10 million will be awarded in the summer of 2021. An additional $10 million will be allocated among finalists and determined at the award decision stage.

    More information is available here: https://www.leverforchange.org/what-we-do/explore-competitions/increasing-womens-power-and-influence/

  • Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional) - Letter of Intent by September 4

    The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.

    Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-20-172.html

    Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

                                                            NIH OER Webmaster

                                                            FBOWebmaster@OD.NIH.GOV

    If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

  • Addressing Racial Disparities in Cancer Care Proposal  - Apply by September 10

    The American Cancer Society and Pfizer Global Medical Grants are collaborating to offer a new competitive grant opportunity focused on addressing systemic race-related barriers that contribute to disparities in outcomes among Black men and women with cancer.

    This Request for Proposals (RFP) is more comprehensive than the collaborative RFP released by Pfizer and ACS on June 11 focused on Prostate Cancer Disparities. This new opportunity is not specific to one cancer type. Proposals should identify and address systemic race-related barriers and disparities in the delivery of care that impact outcomes regardless of cancer type. At a time when racism is at the center of our national conversation, we must aspire to reduce disparities and strive for equity in the delivery of cancer care. In order to accelerate the timeline for this RFP, Letters of Intent are not requested. Full proposals are required for all submissions.

    The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, free lodging near treatment centers, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is the only organization attacking cancer from every angle. For more information about the American Cancer Society, go to www.cancer.org.

    Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

    Pfizer’s GMG competitive grant program involves a publicly posted RFP that provides detail regarding a specific area of interest, sets timelines for review and approval, and works with an external partner or uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in health care as outlined in the RFP.

    For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

    Date RFP Issued: July 15, 2020

    Geographic Scope: United States

    Clinical Area: Oncology - General

    Link to full RFP: Addressing Racial Disparities in Cancer Care

    Application Due Date: September 10, 2020

    Specific Area of Interest: The intent of this grants program is to support quality improvement projects that reduce systemic barriers and address disparities in the delivery of cancer care impacting outcomes for Black men and women facing cancer.

    It is expected that projects are built on the foundation of an evidence based approach and the proposed research/evaluation plan will follow generally accepted scientific principles. During review, the intended outcome(s) of the project will be given careful consideration and projects with the maximum likelihood to directly impact patient care for Black patients across multiple cancer types and those that may be scaled or replicated will be given high priority.

    Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to the Pfizer Grant Officer, Jacqueline Waldrop (Jacqueline.Waldrop@pfizer.com) or to Karla Wysocki at the American Cancer Society (Karla.Wysocki@cancer.org).

  • Discovery Awards - Apply by September 28

    In 2015, the president, provost, and the deans of the University announced a new funding program for innovative, collaborative research or creative projects.

    More than ever, the answers to the most challenging questions cannot be accomplished entirely within one academic discipline, or even one division. The Johns Hopkins Discovery Awards provide grant awards to cross-divisional teams, comprised of faculty and/or non-faculty members from at least two schools or affiliates of the university, who are poised to arrive at important discoveries or creative works.

    The expectation is that these awards will spark new, synergistic interactions between investigators across the institution and lead to work of the highest quality and impact. These awards are not intended to support already established projects or minimal extensions of ongoing research or professional programs.

    Due to the COVID-19 pandemic, the application deadline for the 2020 awards has been delayed to September 28, 2020 at 11:59 PM. 2020 awards will be announced in December. It is anticipated that approximately 30 Discovery Awards will be made this cycle. The 2020 RFA is the sixth annual cycle.

    Funding: 

    Teams may request up to $100,000, with an award term of one to two years, to explore a new area of collaborative work. Support may be used for salary, graduate students, postdoctoral fellows or technicians, equipment, travel, and/or consumables. Applicants must describe a credible plan that assures they will make substantial progress during their funding period.

    The aim of this program is to incite novel interactions within JHU; therefore, no more than 10% of the grant should be allocated as a subaward.

    For any Discovery Award proposals that include APL, ensure that the APL co-PI(s) coordinates their proposal with Alan Ravitz (Alan.Ravitz@jhuapl.edu) and Mitch Smallwood (Mitchell.smallwood@jhuapl.edu) prior to final proposal submission to JHU.

    Review Criteria:

    The review process will evaluate the innovativeness of the project, its potential long-term impact and the synergy expected to result from the proposed crossdivisional collaboration. Collaborators who have worked and published together in the past are not excluded, but the project itself must be both highly innovative and as of yet unfunded. Applications will also be judged on the likelihood of success in attaining future funding. Proposals will be reviewed by a panel of distinguished faculty.

    Post-Award Requirements: 

    Recipients will submit a final progress report, including any completed work, reports of invention, and any external funding applications/awards enabled by this funding. Recipients may also be asked to present their work at a Provost Research Symposium.

    For more information on how to apply and application guidelines, click here.

  • Broad PCORI: Cycle 3 2020 (for Addressing Disparities, Assessment of Options, Communication and Dissemination Research, Improving Healthcare Systems) - Letter of Intent by September 29

    The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our priority areas for research. This PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research, and Improving Health Systems. These broad areas encompass the patient-centered comparative CER we support.

    Our National Priorities for Research and Research Agenda is a framework to guide our funding of comparative clinical effectiveness research that will give patients and those who care for them the ability to make better-informed health decisions. The framework was developed by workgroups of our Board of Governors, members of our Methodology Committee, and staff.

    Applications should address needs of patients, caregivers, clinicians, and other healthcare stakeholders in making personalized clinical decisions across a wide range of conditions, populations, and treatments. Note: In general, PCORI will not cover costs for interventions that are being compared in the proposed study.

    For this cycle, the maximum project budget (direct costs) and maximum research project periods for each priority area are listed below, with changes from previous cycles noted with an * (asterisk) at the end.

    • Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Healthcare Systems:
      • Small: $3 million; 3 years*
      • Large: $5 million; 5 years*
    • Communication and Dissemination Research: $2 million; 3 years

    We are also soliciting proposals for studies that address high-priority methodological gaps in patient-centered outcomes research and CER. Our online system opens on September 1 with Letters of Intent due September 29. Click here for more information.

  • Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations - Apply by December 15

    The COVID-19 pandemic and its associated mitigation strategies are expected to have significant psychosocial, behavioral, and socioeconomic impacts on health, which are exacerbated in populations that experience health disparities and other vulnerable groups, leading to disproportionately adverse consequences. Those experiencing health disparities prior to the COVID-19 pandemic are at increased risk of infection and other COVID-19 related consequences (e.g., job loss, unpaid leave, lost wages).

    Research is needed to test community interventions focused on the prevention (or slowing) of COVID-19 transmission, evaluate local and state policies and programs intended to mitigate COVID-19 exposure and improve adherence, and reduce the negative impact of the multifaceted consequences on the health of populations who experience health disparities and other vulnerable groups. This work may include leveraging and scaling existing resources (e.g., health education materials, technology, social media, mass media, social support networks, social services). In domains and populations in which the evidence base is limited, the development, testing, and implementation of novel or adapted interventions to address the negative health consequences of the COVID-19 pandemic (including the unintended health consequences of population-level interventions) may also be needed to address the unique needs of populations.

    Research Objectives:

    Projects may evaluate existing or ongoing community-based programs or policies (i.e., natural experiments), or prospectively test new or adapted interventions. Multilevel interventions that do not solely target individuals, but also address the upstream determinants that influence individual functioning and health outcomes are strongly encouraged. Projects should be designed to test hypotheses about mechanisms of action that account for an intervention’s effects; mechanisms may operate at any level of analysis.

    Projects must include a focus on one or more NIH-designated populations that experience health disparities in the United States, or a population identified as vulnerable to COVID-19 infection, hospitalization,or mortality.

    Applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020 by 5:00 PM local time of the applicant organization. For more application information, click here.

  • Evidence for Action: Investigator-Initiated Research to Build a Culture of Health - Open Deadline

    Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation (RWJF), funds research that expands the evidence needed to build a Culture of Health. A Culture of Health is broadly defined as one in which good health and well-being flourish across geographic, demographic, and social sectors; public and private decision-making is guided by the goal of fostering equitable communities; and everyone has the opportunity to make choices that lead to healthy lifestyles. RWJF’s Culture of Health Action Framework, which was developed to catalyze a national movement toward improved health, well-being, and equity, guides E4A’s program strategy.

    Eligibility and Selection Criteria

    Preference will be given to applicants that are either institutes of higher education, public entities, or nonprofit organizations that are tax exempt under Section 501(c)(3) of the Internal Revenue Code and are not private foundations or Type III supporting organizations. Other types of nonprofit and for-profit organizations are also eligible to apply. The Foundation may require additional documentation. Applicant organizations must be based in the United States or its territories. Submissions from teams that include both U.S. and international members are eligible, but the lead applicant must be based in the United States.

    Key Dates

    We hosted an applicant webinar on April 12, 2019.

    During the webinar, we:

    • Reviewed our updated Call for Proposals and the different phases in the application process
    • Discussed what it means to be an E4A grantee
    • Hosted a live Q&A period with participants.

    A recording is available here.

    Since applications are accepted on a rolling basis, there is no deadline for submission. Generally, applicants can expect to be notified within 6-9 weeks of their LOI submission. Applicants invited to the full proposal stage will have 2 months to submit their proposal once they receive notification. Full proposal funding decisions will generally be made within 6-9 weeks of the submission deadline.

    Total Awards

    There is not an explicit range for allowable budget requests. You should request the amount of funding you will need to complete your proposed research project – including both direct and indirect costs for the entire duration of your study. Typical grant durations may be up to 36 months, with some exceptions when durations of up to 48 months are justified. Visit the Grantee section of our website for a sense of the number and size of grants funded by E4A at http://www.evidenceforaction.org/grantees.

    For more information on how to apply, click here.

  • Pioneering Ideas: Exploring the Future to Build a Culture of Health - Open Deadline

    Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.

    We want to hear from scientists, anthropologists, artists, urban planners, community leaders—anyone, anywhere who has a new or unconventional idea that could alter the trajectory of health, and improve health equity and well-being for generations to come. The changes we seek require diverse perspectives and cannot be accomplished by any one person, organization or sector. 

    Eligibility and Selection Criteria

    Preference will be given to applicants that are tax exempt under Section 501(c)(3) of the Internal Revenue Code and are not private foundations or Type III supporting organizations. Applicant organizations must be based in the United States or its territories. Submissions from teams that include both U.S. and international members are eligible, but the lead applicant must be based in the United States.

    Applications will be evaluated based on, but not limited to, the following criteria:

    • Strength of health equity focus: How will this project increase opportunities for everyone to live the healthiest life possible, no matter who they are, where they live, or how much money they make? 
    • Strength of insight: How will this project help us anticipate, adapt to, and influence the future in 5 to 15 years?
    • Strength of idea: Is this project pioneering in one or more of these ways?
      • Offers a new take or perspective on a long-running, perplexing problem
      • Challenges assumptions or cultural practices
      • Takes an existing idea and gives it a new spin—or a novel application
      • Applies ideas from other fields
      • Explores how an emerging trend will shape the future
      • Describe in which other way you see your project as pioneering

    Key Dates

    Proposals will be accepted throughout the year on a rolling admission.  

    Total Awards

    The average Pioneer grant in 2019 was $315,031. However, there is not an explicit range for budget requests. Grant periods are flexible, though generally range from 1 to 3 years.

    Click here to apply.

  • Research Supplements to Promote Diversity in Health-Related Research - Various Deadlines

    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project.

    This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.   

    This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

    In all cases, the proposed research experience must be an integral part of the approved, ongoing research of the parent award, and it must have the potential to contribute significantly to the research career development of the candidate.

    Award Information: Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project. Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate. Administrative supplements end with the currently funded competitive cycle of the parent grant. Budget requests may also be limited by the awarding IC. 

    Application Deadline: Due dates vary by awarding IC; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    For more information, click here. 

  • Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 - Various Deadlines

    This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.

    Application Due Dates: August 20, 2020, December 2, 2020, March 2, 2021

    • All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
    • Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Please click here for more information.

  • Notices of Special Interest (NOSIs) - Various Deadlines

     


    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

    Notice Number:
     NOT-OD-20-097

    Expiration Date: April 1, 2021

    Purpose:
    This NOSI highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts,including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.

    View NOT-OD-20-097

    Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

    Notice Number: NOT-HL-20-757

    Expiration Date: October 6, 2020

    Purpose:
    The National Heart, Lung, and Blood Institute (NHLBI) is issuing this NOSI to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

    View NOT-HL-20-757



    Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2

    Notice Number:
     NOT-GM-20-025

    Expiration Date: February 6, 2021

    Purpose:
    The National Institute of General Medical Sciences (NIGMS) is issuing this NOSI to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19).

    View NOT-GM-20-025


    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

    Notice Number:
     NOT-DA-20-047

    Expiration Date: March 31, 2021

    Purpose:
    The National Institute on Drug Abuse (NIDA) is issuing this NOSI to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

    View NOT-DA-20-047


    Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus

    Notice Number:
     NOT-MH-20-047

    Expiration Date: April 16, 2021

    Purpose:
    The National Institute of Mental Health (NIMH) is issuing this NOSI to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. NIMH is especially interested in research to provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH.

    View NOT-MH-20-047


    Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

    Notice Number:
     NOT-AG-20-022

    Expiration Date: May 1, 2021

    Purpose:
    The National Institute on Aging (NIA) is issuing this NOSI to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). The mission of NIA is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging. This NOSI supports mission critical areas of research for NIA as they relate to the COVID-19 pandemic.

    View NOT-AG-20-022


    Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)

    Notice Number:
     NOT-AT-20-011

    Applications will be accepted on a rolling basis through October 6, 2020 by 5:00 p.m. local time of the applicant organization. This NOSI expires on October 7, 2020.

    Purpose:
    The National Center for Complementary and Integrative Health (NCCIH) is issuing this NOSI to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.

    View NOT-AT-20-011


    Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
     

    This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities.

    Expiration Date: September 9, 2020

    Please click here for more information.

    View NOT-AT-20-011


    Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

    Projects may evaluate existing or ongoing community-based programs or policies (i.e., natural experiments), or prospectively test new or adapted interventions. Multilevel interventions that do not solely target individuals, but also address the upstream determinants that influence individual functioning and health outcomes are strongly encouraged. Projects should be designed to test hypotheses about mechanisms of action that account for an intervention’s effects; mechanisms may operate at any level of analysis.

    Key questions include: To what extent do existing interventions slow the spread of COVID-19 in specific populations and geographic hotspots? To what extent do policies, guidelines, and other interventions facilitate adherence and mitigate the multifaceted impacts of COVID-19 on health in populations that experience health disparities and vulnerable groups? Can established models of crisis and disaster response and management be applied to address the needs of health disparity and other vulnerable populations?

    Outcomes of interest include, but are not limited to, COVID-19 incidence, hospitalizations, and mortality rates in defined populations or geographic locations, indicators of community functioning and/or family functioning related to health, changes in the physical or built environment, preventative behaviors, adherence to mitigation strategies, access and utilization of health care, management of chronic conditions (provider-delivered care and/or self-management), mental health, substance abuse, tobacco use, dietary intake, sleep health, quality of life (QoL), physical activities, activities of daily living (ADLs), instrumental activities of daily living (IADLs), and biomarkers and other outcomes of health.

    Projects must include a focus on one or more NIH-designated populations that experience health disparities in the United States, or a population identified as vulnerable to COVID-19 infection, hospitalization, or mortality.

     

    Expiration Date: December 30, 2020

    Please click here for more information.

  • 2020 Reimagine Education Awards - Open Deadline

    QS Quacquarelli Symonds – compilers of the QS World University Rankings – and The Wharton School have now opened the 2020 Reimagine Education Awards, which are offering $50,000 and global visibility to an outstanding approach to teaching or learning.

    The Awards were contested by 1518 university faculty, cross-departmental teams, and edtech companies in 2019, and have received over 5000 submissions since their 2014 inauguration – making them currently the world’s largest educational awards program.

    Previous winners include Harvard University, Massachusetts Institute of Technology, Imperial College London, and the London School of Economics.

    There are also 14 Category Award Winners – with categories including Virtual Reality, Artificial Intelligence, Hybrid Learning, Presence Learning, and Best Educational App – and awards available for outstanding submissions by region and by discipline.

    All applications can be made free of charge, and can be submitted by visiting www.Reimagine-Education.com/application. There is no restriction on the number of unique applications that can be made by an individual institution or department.

  • Johns Hopkins University Center for AIDS Research (CFAR) Small Grants Program - Various Deadlines

    The purpose of the small grants program is to offer financial assistance for HIV/AIDS research outside of our usual award mechanisms, on an ongoing basis.

    Funds are to be used to:

    Collect or analyze data/specimens to inform a research application (new or under revision for re-submission) Provide incentives to enhance/expand enrollment Provide salary support for staff or a student to expand or add an aim to an existing protocol. Extend currently funded research (i.e. expand analysis, enlarge scope) Overcome an obstacle to currently funded research or application (i.e. Advertising, Grant writer) Test the feasibility of an idea (acceptability of intervention, recruitment method, etc.) Preliminary Projects (Focus groups, qualitative interviews, survey) Manuscript preparation Other needs? Just ask.

    Application Submission:

    Interested applicants are encouraged to contact before beginning the application process, in order to discuss the fit of your request with the CFAR goals for the Small Grants Program.

    Complete an application package HERE

    The application package should include the following:

    A completed “Small Grants” request form

    A copy of the applicant’s NIH biosketch

    Eligibility:

    Any CFAR member who meets the NIH definition of “Early Stage Investigator Senior faculty will be considered on an exceptional ad hoc basis

    Any Hopkins faculty member or post-doc conducting HIV/AIDS research

    This program provides reimbursement or direct purchases of up to $5,000 per approved request.

    Approvals:

    Projects that require institutional approvals (e.g. IRB, IACUC) must have copies of those approvals on file with the Developmental Core before funds will be released.

    Deadlines:

    Rolling. Submissions will be circulated for review by the CFAR Developmental Core and other invited reviewers and a decision made within 4 weeks of application.

  • RWJF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health - Open Deadline

    Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

    Open Deadline

    Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Our mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships. We are especially interested in research examining the health impacts of programmatic or policy interventions that address factors outside the domain of health care services or public health practice.

  • The Kresge Foundation: Advancing innovative, multi-sectoral policy solutions in human services - Open Deadline

    The Kresge Foundation: Advancing innovative, multi-sectoral policy solutions in human services

    Open Deadline

    From our experience with human services organizations and networks, we continue to learn about the best approaches that can be replicated and shared across the field. We want to help these groundbreaking ideas enter the mainstream at the state and national level and encourage collaboration across multiple sectors including the public sector, private sector, philanthropy and nonprofit organizations.

  • France-Merrick Foundation- Open Deadline

    France-Merrick Foundation

    Deadline: Open
    The Foundation is specifically interested in improving health and wellness, with a focus on prevention and population health.  Furthermore, the Foundation is focused on increasing access to care for disadvantaged populations and strengthening health care provision in community based settings. Due to the Foundation’s concurrent interest in community development, the Foundation also supports anchor health institutions in improving neighborhoods around their hospital with dual health and community development benefits. 
  • Amgen Foundation Grants- Open Deadline

    Amgen Foundation Grants

    Open Application Deadline

    Our focus is to fund programs that enhance civic engagement by supporting science and education based initiatives, environmental programs, social services, as well as culture and arts in an effort to strengthen and enrich our communities.

  • Anderson-Rogers Foundation- Open Deadline

    Anderson- Rogers Foundation

    Open Deadline

    The Anderson-Rogers Foundation makes grants to 501(c)(3) organizations that address a variety of social and environmental needs. The Foundation is particularly interested in funding programs in the following areas:

    Reproductive and abortion rights Access to contraception and sex education, particularly programs aimed at reducing teen pregnancy rates Environmental education and activism, including programs to preserve and restore habitat and protect endangered animals Promotion of environmentally sound agricultural practices and food systems Promotion of humanist values and separation of church and state

  • Alfred P. Sloan - Working Longer Program- Rolling Deadline

    Alfred P. Sloan - Working Longer Program

    https://sloan.org/programs/working-longer#apply

    Deadline: Rolling

    In selecting projects for funding, the Foundation seeks proposals for original initiatives led by outstanding individuals or teams.  We are interested in projects that have a high expected return to society, exhibit a high degree of methodological rigor, and for which funding from the private sector, government, or other foundations is not yet widely available.  Founded in 2010, our Working Longer program is examining one of today’s most pressing social issues: older workers who need or want to work beyond conventional retirement ages. 

  • Semnani Family Foundation- Rolling Deadline
    Semnani Family Foundation Grants

    Deadline: Rolling

    Grant Amount: $27,000,000

    For additional information visit http://semnanifamilyfoundation.org/

    The Semnani Family Foundation focuses primarily on promoting the health, education and disaster relief for marginal communities in the United States and around the world. Program areas include social issues, health, children, women, disaster relief, Iranian American issues, religious tolerance and interfaith dialogue.

    The philosophy of the Foundation is guided by a desire to empower the most vulnerable members of society, where ever they may be. The Semnani Family Foundation seeks to leverage its resources in a cost effective and efficient manner that delivers the maximum benefit to help the most marginal of communities—those who would otherwise be left out, forgotten or neglected, or those who would risk serious and irreversible damage and injury from exposure to natural or man-made disasters such as famine, floods, earthquakes and war.

  • CIGNA World of Difference Grant Program- Rolling Deadline
    CIGNA World of Difference Grant Program: Community Health Navigation Grant

    Grant amount: US $50,000 - US $150,000

    Deadline: Rolling

    To encourage Health Equity, we are currently seeking proposals from non-profit organizations engaged in eliminating Health Disparities and improving Community Health Navigation.
  • NIH Fogarty International Center Funding Opportunities

    NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.


    (R01 Basic Experimental Studies with Humans Required) (PAR-19-384) and (R01 Clinical Trials Not Allowed) (PAR-19-373)Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery

    Application Receipt Dates: March 17, 2021


    (F32) (PAR-19-379) and (F31) (PAR-19-378)Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases. Application Receipt Dates: Standard dates apply; Note: May request support for training abroad.

  • Funding News Updates

    nih sample grant applications, summary statements, and more...

    Sample Grant Applications, Summary Statements, and More

    If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more. Continue reading 

    New Salary Cap for NIH Grants : $192,300

    Effective, January 6, 2019, the salary limitation for Executive Level II is $192, 300. For awards issued in those years that were restricted to the prior Executive Level II, including competing awards already issued in FY2019, if adequate funds are available in active awards, and if the salary cap increase is consistent with the institutional base salary, grantees may rebudget funds to accommodate the current Executive Level II salary level.  However, no additional funds will be provided to these grant awards.

    Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements (NOT-OD-19-098)

    Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements (NOT-OD-19-098)

    Reminder for NIH Grants submitted on or after January 25, 2019: Inclusion Across the Lifespan

    The policy applies to all NIH conducted or supported research involving human subjects, including research that is otherwise “exempt” under the new Common Rule.

    Policy: Individuals of all ages, including children and older adults, must be included in all human subjects research, unless there are scientific or ethical reasons not to include them.

    Applications for research involving human subjects must address the age-appropriate inclusion or exclusion of individuals in the proposed research project. Applications must include a description of plans for including individuals in the proposed research project including a rationale for selecting the specific age range justified in the context of the scientific question proposed. If individuals will be excluded from the research based on age, the proposal must include an acceptable justification for the exclusion.

    The policy applies to all NIH conducted or supported research involving human subjects, including research that is otherwise “exempt” under the new Common Rule

    Policy: Individuals of all ages, including children and older adults, must be included in all human subjects research, unless there are scientific or ethical reasons not to include them.

    Applications for research involving human subjects must address the age-appropriate inclusion or exclusion of individuals in the proposed research project. Applications must include a description of plans for including individuals in the proposed research project including a rationale for selecting the specific age range justified in the context of the scientific question proposed. If individuals will be excluded from the research based on age, the proposal must include an acceptable justification for the exclusion.

    The Federal Common Rule lays out requirements for IRBs

    The Federal Common Rule lays out requirements for IRBs. Effective 1/21/19, the REVISED Common Rule takes effect.

    One part of the changes deals with what constitutes exempt research (not requiring IRB review or requiring just a limited review)

    Changes are set forth in the link below:  

    https://www.medstarhealth.org/mhri/focusblog/2018/01/07/revised-common-rule-changes-mean-research/

    Questions? Please contact Deb Brodlie, Director, Sponsored Projects and Business Development

    Revised NIH Grants Policy Statement for Fiscal Year 2019

    NIH has released a revised Grants Policy Statement that applies to all NIH grants and cooperative agreements with budget periods beginning on or after October 1, 2018. This revised version does not introduce new policies, but it does incorporate all policy changes or updates made throughout the previous year and includes significant enhancements to improve the user interface, navigation, and search. Continue reading →

    New Application Requirements for Institutional Training Grants:

    Letter of Institutional Commitment to Harassment and Discrimination Protections

    NIH takes the issue of sexual harassment and discrimination very seriously. As such, beginning with applications submitted for due dates on or after January 25, 2019, institutional training grant applications (T15, T32, T34, T35, T36, T37, T90/R90, TL1, TL4) must include a letter that describes the institutional commitment to ensuring that proper policies, procedures, and oversight are in place to prevent discriminatory harassment and other discriminatory practices. Continue reading →


    LEARN MORE

    Legislative Mandates for Fiscal Year 2019

    NIH issued a notice detailing statutory provisions that limit or condition the use of funds on NIH grant, cooperative agreement, and contract awards for FY 2019. These provisions include:

    Salary Limitation Gun Control

    For additional details, see NOT-OD-19-030.

    Anti-Lobbying Acknowledgment of Federal Funding Restriction on Abortions, with exceptions Ban on Funding Human Embryo Research Limitation on Use of Funds for Promotion of Legalization of Controlled Substances Restriction on disclosure of political affiliation for Federal scientific advisory committee candidates Dissemination of False or Misleading Information Restriction of Pornography on Computer Networks Restriction on Distribution of Sterile Needles

  •